|
1
|
Caplan AI: Mesenchymal stem cells. J
Orthop Res. 9:641–650. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedenstein AJ, Gorskaja JF and Kulagina
NN: Fibroblast precursors in normal and irradiated mouse
hematopoietic organs. Exp Hematol. 4:267–274. 1976.PubMed/NCBI
|
|
3
|
Pittenger MF, Mackay AM, Beck SC, et al:
Multilineage potential of adult human mesenchymal stem cells.
Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang Y, Jahagirdar BN, Reinhardt RL, et
al: Pluripotency of mesenchymal stem cells derived from adult
marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL
and Chen TH: Isolation of multipotent mesenchymal stem cells from
umbilical cord blood. Blood. 103:1669–1675. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song H, Song BW, Cha MJ, Choi IG and Hwang
KC: Modification of mesenchymal stem cells for cardiac
regeneration. Expert Opin Biol Ther. 10:309–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mizuno H: Adipose-derived stem cells for
tissue repair and regeneration: ten years of research and a
literature review. J Nippon Med Sch. 76:56–66. 2009.PubMed/NCBI
|
|
8
|
Bianco P, Robey PG and Simmons PJ:
Mesenchymal stem cells: revisiting history, concepts, and assays.
Cell Stem Cell. 2:313–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fong D, Moser P, Krammel C, et al: High
expression of TROP2 correlates with poor prognosis in pancreatic
cancer. Br J Cancer. 99:1290–1295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fong D, Spizzo G, Gostner JM, et al:
TROP2: a novel prognostic marker in squamous cell carcinoma of the
oral cavity. Mod Pathol. 21:186–191. 2008.PubMed/NCBI
|
|
11
|
Muhlmann G, Spizzo G, Gostner J, et al:
TROP2 expression as prognostic marker for gastric carcinoma. J Clin
Pathol. 62:152–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakashima K, Shimada H, Ochiai T, et al:
Serological identification of TROP2 by recombinant cDNA expression
cloning using sera of patients with esophageal squamous cell
carcinoma. Int J Cancer. 112:1029–1035. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohmachi T, Tanaka F, Mimori K, Inoue H,
Yanaga K and Mori M: Clinical significance of TROP2 expression in
colorectal cancer. Clin Cancer Res. 12:3057–3063. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Day R, Dong Y, Weintraub SJ and
Michel L: Identification of Trop-2 as an oncogene and an attractive
therapeutic target in colon cancers. Mol Cancer Ther. 7:280–285.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goldstein AS, Lawson DA, Cheng D, Sun W,
Garraway IP and Witte ON: Trop2 identifies a subpopulation of
murine and human prostate basal cells with stem cell
characteristics. Proc Natl Acad Sci USA. 105:20882–20887. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okabe M, Tsukahara Y, Tanaka M, et al:
Potential hepatic stem cells reside in EpCAM+ cells of
normal and injured mouse liver. Development. 136:1951–1960. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hall B, Limaye A and Kulkarni AB:
Overview: generation of gene knockout mice. Curr Protoc Cell Biol.
Chapter 19(Unit 19.12): 19.12.1–17. 2009. View Article : Google Scholar
|
|
18
|
Zhu H, Guo ZK, Jiang XX, et al: A protocol
for isolation and culture of mesenchymal stem cells from mouse
compact bone. Nat Protoc. 5:550–560. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun S, Guo Z, Xiao X, et al: Isolation of
mouse marrow mesenchymal progenitors by a novel and reliable
method. Stem Cells. 21:527–535. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo Z, Li H, Li X, et al: In vitro
characteristics and in vivo immunosuppressive activity of compact
bone-derived murine mesenchymal progenitor cells. Stem Cells.
24:992–1000. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maxson S, Lopez EA, Yoo D,
Danilkovitch-Miagkova A and Leroux MA: Concise review: role of
mesenchymal stem cells in wound repair. Stem Cells Transl Med.
1:142–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y, Chen L, Scott PG and Tredget EE:
Mesenchymal stem cells enhance wound healing through
differentiation and angiogenesis. Stem Cells. 25:2648–2659. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cubas R, Li M, Chen C and Yao Q: Trop2: a
possible therapeutic target for late stage epithelial carcinomas.
Biochim Biophys Acta. 1796:309–314. 2009.PubMed/NCBI
|
|
24
|
Yu FX, Sun HQ, Janmey PA and Yin HL:
Identification of a polyphosphoinositide-binding sequence in an
actin monomer-binding domain of gelsolin. J Biol Chem.
267:14616–14621. 1992.PubMed/NCBI
|
|
25
|
Linnenbach AJ, Seng BA, Wu S, et al:
Retroposition in a family of carcinoma-associated antigen genes.
Mol Cell Biol. 13:1507–1515. 1993.PubMed/NCBI
|
|
26
|
El Sewedy T, Fornaro M and Alberti S:
Cloning of the murine TROP2 gene: conservation of a PIP2-binding
sequence in the cytoplasmic domain of TROP-2. Int J Cancer.
75:324–330. 1998.PubMed/NCBI
|
|
27
|
Taniguchi CM, Tran TT, Kondo T, et al:
Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses
insulin action via positive regulation of PTEN. Proc Natl Acad Sci
USA. 103:12093–12097. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wan X, Dennis AT, Obejero-Paz C, et al:
Oxidative inactivation of the lipid phosphatase and tensin homolog
on chromosome ten (PTEN) as a novel mechanism of acquired long QT
syndrome. J Biol Chem. 286:2843–2852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Datta SR, Dudek H, Tao X, et al: Akt
phosphorylation of BAD couples survival signals to the
cell-intrinsic death machinery. Cell. 91:231–241. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brunet A, Bonni A, Zigmond MJ, et al: Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song G, Ouyang G and Bao S: The activation
of Akt/PKB signaling pathway and cell survival. J Cell Mol Med.
9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Re RN and Cook JL: Senescence, apoptosis,
and stem cell biology: the rationale for an expanded view of
intracrine action. Am J Physiol Heart Circ Physiol. 297:H893–H901.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sethe S, Scutt A and Stolzing A: Aging of
mesenchymal stem cells. Ageing Res Rev. 5:91–116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lindsley CW: The Akt/PKB family of protein
kinases: a review of small molecule inhibitors and progress towards
target validation: a 2009 update. Curr Top Med Chem. 10:458–477.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Litvinov SV, Velders MP, Bakker HA,
Fleuren GJ and Warnaar SO: Ep-CAM: a human epithelial antigen is a
homophilic cell-cell adhesion molecule. J Cell Biol. 125:437–446.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maetzel D, Denzel S, Mack B, et al:
Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell
Biol. 11:162–171. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Zhang K, Grabowska D, et al: Loss
of Trop2 promotes carcinogenesis and features of epithelial to
mesenchymal transition in squamous cell carcinoma. Mol Cancer Res.
9:1686–1695. 2011. View Article : Google Scholar : PubMed/NCBI
|
